Growth Metrics

Tandem Diabetes Care (TNDM) Capital Expenditures Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 111.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 111.40%
Dec 31, 2025 222.15%
Sep 30, 2025 -104.64%
Jun 30, 2025 -129.26%
Mar 31, 2025 -33.48%
Dec 31, 2024 16.12%
Sep 30, 2024 -2.98%
Jun 30, 2024 -46.71%
Mar 31, 2024 9.48%
Dec 31, 2023 -431.60%
Sep 30, 2023 -60.61%
Jun 30, 2023 0.14%
Mar 31, 2023 54.03%
Dec 31, 2022 -57.48%
Sep 30, 2022 2,680.93%
Jun 30, 2022 2,667.16%
Mar 31, 2022 186.04%
Dec 31, 2021 2,569.22%
Sep 30, 2021 -23.09%
Jun 30, 2021 91.85%
Mar 31, 2021 -86.34%
Dec 31, 2020 -103.14%
Sep 30, 2020 -71.45%
Jun 30, 2020 -395.21%
Mar 31, 2020 380.54%
Dec 31, 2019 482.35%
Sep 30, 2019 6,514.29%
Jun 30, 2019 -835.20%
Mar 31, 2019 548.85%
Dec 31, 2018 -48.12%
Sep 30, 2018 99.12%
Jun 30, 2018 -103.27%
Mar 31, 2018 -5.24%
Dec 31, 2017 105.83%
Sep 30, 2017 -286.21%
Jun 30, 2017 6.07%
Mar 31, 2017 -48.07%
Dec 31, 2016 64.25%
Sep 30, 2016 -17.22%
Jun 30, 2016 296.37%
Mar 31, 2016 -26.50%
Dec 31, 2015 123.86%
Sep 30, 2015 166.39%
Jun 30, 2015 -14.95%
Mar 31, 2015 -62.96%
Dec 31, 2014 -49.59%
Sep 30, 2014 -12.92%
Jun 30, 2014 107.78%
Mar 31, 2014 79.78%